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Abstract
Exocytosis is the process by which cells release various molecules into the extracellular
space. This mechanism is accomplished by membrane fusion, in which the membrane of the
transport vesicle and that of the cell itself fuse to create one continuous membrane, allowing the
release of the molecules inside the vesicle. A family of proteins, known as SNARE proteins, is
responsible for facilitating membrane fusion. SNARE proteins form a complex between the
vesicle membrane and the plasma membrane. For various cells, such as mast cells and neurons,
exocytosis is essential to carry out their vital functions. Various accessory proteins are known to
play a role in membrane fusion by regulating the assembly and disassembly of the SNARE
complex. One family of proteins is known as Munc13 proteins. This protein family has been
shown to regulate SNARE complex formation both positively and negatively in mast cells and
neurons. While three isoforms are cell-specific, Munc13-1 has been found to regulate
degranulation in both neurons and mast cells. In mast cells, Munc13-1 has been found to inhibit
the activity of degranulation stimulating protein Munc13-4, and to decrease the level of antigeninduced degranulation experienced by the cell. However, in neurons, Munc13-1 helps to convert
syntaxin from the closed Munc18-syntaxin formation to the open SNARE complex formation.
This project aims to transform two expression systems with a truncated version of Munc13-1
gene from two different plasmids to use in further studies.
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Chapter 1: Introduction
Cells increase their ability to survive by maintaining a stable state of equilibrium between
themselves and their environment, called homeostasis. One essential function for cells to
maintain homeostasis is the ability to regulate what enters and exits the cellular membrane,
which is regulated by membrane fusion (14). The process of membrane fusion involves the
uniting of two individual membranes as one seamless bilayer and is mediated by various proteins
and complexes (14).
A family of proteins known as Soluble N-ethylmaleimide-sensitive factor attachment
protein receptors proteins (SNARE proteins) is known to catalyze the process of membrane
fusion (9). Three proteins that dominate this complex are Syntaxin, Snap 25, and synaptobrevin/
vesicle-associated membrane protein (VAMP). These three proteins are then further categorized
as either V-SNARES or T-SNARES (9). Syntaxin and SNAP 25-like protein are known as TSNARES, due to their placement on the target membrane of the cell. Synaptobrevin is known as
a V-SNARE because it is located on the actual transport vesicle itself. The SNARE complex is
formed upon the interaction of T-SNARES and V-SNARES from two different membranes (9).
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Figure 1. An external stimulus activates a mast cell. The V-SNARE complexes on the
secretory granule form a trans-SNARE complex with the cis-SNARE complexes (comprising of
SNAP 25 protein and Syntaxin). This trans-SNARE complex allows for the fusion of the two
membranes and the release of the granule contents.
The formation of this complex causes stress to the lipid bilayer and allows for the two
membranes to fuse and release the transport vesicles contents (Figure 1). The specific
mechanism by which cells undergo membrane fusion is not fully understood. The process is
known to be complex, involving a variety of different proteins and modulators (10). Transport
vesicles, such as granules, are packed and processed in the Golgi Apparatus and sent through
various transport carriers to the plasma membrane of the cell (10). Membrane fusion then occurs
between the secretory vesicle membrane and that of the cell itself which leads to release the
contents of the vesicle into the extracellular space (10).
Membrane fusion is a vital part of exocytosis in cells, especially in effector cells such as
mast cells. Degranulation is the name given to a specific form of exocytosis in mast cells, in
which they release the contents of their granules (11). As an effector cell, mast cells sense
changes in environmental stimuli and respond appropriately. Mast cells are a critical component
of the immune system, and their secretory granules are an essential component of their immune
responses (11). A mast cell protects the body against damage from potential pathogens, stress, or
antigens (11). An antigen is any substance capable of warranting an immune response, such as
one carried out by a mast cell. Once an antigen is detected, mast cells are said to be “activated,”
and degranulation occurs approximately 5-10 seconds afterward (11). In degranulation, bioactive
molecules, such as histamines, chemokines, or proteases, stored in secretory granules are
released from the cell to combat extracellular threats (11).
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Both the adaptive and innate immune systems utilize mast cells. However, mast cells are
most commonly associated with allergic reactions and are stimulated by IgE (Immunoglobulin E)
antibodies (15). This Type 1 Hypersensitivity reaction occurs when an antigen binds an antibody,
forming an antigen-antibody complex (15). This complex contains a fragment crystallizable (FC)
region, which binds to an FC receptor on the exterior of the mast cell (15). The binding of the FC
receptor on the mast cell to the FC region on the antigen-antibody complex activates the mast
cell, which undergoes degranulation and releases a variety of mediators that will carry out an
immune response (Figure 2).

Figure 2. Antibodies made by plasma cells bind antigens, forming antigen-antibody
complexes. An antigen-antibody complex then binds specific receptors on the surface of a mast
cell and activates the cell. The activated mast cell then releases effector molecules, and a cellular
response occurs.
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Although the mechanism of membrane fusion appears to be highly conserved in all
eukaryotic organisms, the regulation of this process varies. The regulation of mast cell
degranulation complex is important because unregulated or miss-regulated degranulation can
lead to hyper-inflammation and tissue damage. Initially, studies to curb destructive mast cell
degranulation focused on preventing the formation of the antigen-antibody complex with IgE.
However, recent findings have pointed towards the regulation of the assembly and disassembly
of the SNARE complex as a possible source of therapeutic treatment. For this reason, the
accessory proteins that help regulate mast cell degranulation are of great interest.
One family of proteins that is associated with the regulation of SNARE mediated
membrane fusion are the Mammalian uncoordinated13 proteins (Munc13 proteins). A defining
feature of Munc13 proteins is their various domains, such as C2 domains, phospholipid binding
domains, and calcium binding domains, which interact directly with SNARE proteins (3).
Munc13-4 is an isoform of the Munc13 protein that is highly associated with mast cell
degranulation and is theorized to play a role in vesicle priming (3). Support for this theory comes
from a 2018 study that showed rat mast cells with a deleterious mutation in Munc13-4 were able
to dock secretory vesicles, but unable to perform exocytosis fully (3). The terminal end of the
C2A domain Munc13-4 has been identified to participate in priming by stabilizing the secretory
granule and restricting its movement abilities both in the binding of Rab27a and at the plasma
membrane (5). However, another isoform has been found to play a role in the negative regulation
of degranulation. Recent studies have found evidence that Munc13-1 may inhibit degranulation
in mast cells via suppression of Munc13-4 (6). Experiments using mast cells with Munc13-1
knockdown showed a significant increase in antigen-induced degranulation in mast cells (6).
Likewise, it was found that the overexpression of Munc13-1 led to a significant reduction in
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antigen-induced degranulation. In addition to the decrease in degranulation, the overexpression
of Munc13-1 led to a decrease in the expression of Munc13-4, thus suggesting an inhibitory
effect on the production of the protein (6).
Mast cells, however, are not the only cell in which exocytosis is a vital function. Neurons
are cells that play a fundamental role in the nervous system by performing exocytosis to release
neurotransmitters (16). Like other cells neurons receive signals from the environment and
respond accordingly (16). However, these highly specified cells are different from mast cells by
the way in which they carry out a response. Neurons work by sending electrical messages to one
another using action potential as a method to power the signal, a term known as neuron “firing”
(16). First, much like any other cellular response, there must be an environmental shift the
neuron becomes aware of. In the case of neurons, this signal is the disruption of normal
concentrations levels in the cells membrane (13). The altering of concentrations leads to
depolarization, followed by repolarization which results in the generation of action potential
(13). The action potential propagates down the axon to where it reaches the axon terminal. Upon
reaching the axon terminal, an influx of Ca2+ rushes into the cell, and allows the membrane of
the synaptic vesicle to fuse with that of the neuron membrane, thus releasing the contents of the
vesicle into the synapse (Figure 3).
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Figure 3. Action potential travels from the soma (cell body) of the neuron down the axon. Once
it reaches the axon terminal, neurotransmitters are released into the synapse where the chemical
signal will be received by another neuron.
A fundamental difference between mast cell degranulation and that of the release of
neurotransmitters by neurons is the “green light” in which they receive to perform exocytosis.
Mast cells are activated by the formation and binding of an antibody-antigen complex, as
previously discussed. Neurons, on the other hand, are only able to undergo degranulation once an
action potential reaches the axon terminus (13). However, neurotransmitter release in neurons is
very similar to degranulation in mast cells, such as the mechanism of SNARE complex
formation, using the same T-SNARES and V-SNARES (Figure 4). Likewise, proteins from the
Munc13 family are also heavily involved in the regulation of the SNARE complex formation in
neurotransmitter release (16).
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Figure 4. After an action potential reaches the axon terminal, the T-SNARES on the transport
vesicle interact with the V-SNARE on the neuron’s membrane, forming the SNARE-complex.
The formation of this complex leads to the release of a neurotransmitter, in this case,
Though previously mentioned to have inhibiting roles in mast cell degranulation, most
functions of Munc13-1 have been identified in neurons, along with Munc13-2 and Munc13-3.
However, Munc13-1 is by far the isoform with the highest amount of expression in the brain of
all the Munc13 isoforms and is believed to participate also in priming of the secretory vesicle
(4). The Munc13-1 isoform is expressed in the olfactory region, the cerebellum, the cortex and
the hippocampus (4). Similar to studies on Munc13-4, studies on mice without Munc13-1
showed a severe limitation in neurotransmitter release (1). Additionally, elimination of this
isoform in both Drosophila uncoordinated 13 (Dunc13-1) and in C. elegans (Unc13-1) yielded
similar results (2 & 12). The isoform Munc13-1 is thought to regulate the priming of a vesicle by
directly interacting with the N-terminal region of Syntaxin (T-SNARE) with a coiled domain of
its own (7). Further studies in mice showed that mice without Munc13-1 or Munc13-2 were
completely unable to release neurotransmitters, and demonstrated severe difficulty with docking
secretory vesicles (4).
Munc13-1 has several active domains which are believed to work alongside an additional
accessory protein, called Munc18, to facilitate membrane fusion (8) (Figure 5).

Figure 5. Munc13-1 gene with three C2 domains, a C1 domain, and a MUN domain.
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Munc18-1 binds Syntaxin to form a Munc18-1/Syntaxin complex, that keeps Syntaxin in
its closed formation (7). This action prevents the SNARE complex from reassembling. The
MUN domain in Munc13-1 catalyzes the movement of Syntaxin from the closed Munc18-1Syntaxin complex to the SNARE complex (7). Additionally, the MUN domain of Munc13-1 has
also been found to assist in the proper configuration of the Syntaxin/ SNAP-25/ Synaptobrevin
complex from the Syntaxin/SNAP-25 complex and the separate Synaptobrevin through
interaction with the cytoplasmic domain of Syntaxin (7). It has also been discovered that
Munc13-1 promotes the proper formation of the Syntaxin/SNAP-25 itself, though the specific
mechanism is not yet known. Domains C1 and C2B are also believed to play vital role in fusion,
as when isoforms without these regions were tested they displayed significantly lower levels of
membrane fusion (7).
As discussed, Munc13-1 has regulation properties in the membrane fusion of both mast
and neuron cells. In mast cells, Munc13-1 helps to combat over degranulation which may lead to
rapid inflammation and tissue damage (15). In neurons, it aids in the priming of the secretory
vesicle and thus the success of releasing neurotransmitters (7). Inability to release or the over
release of neurotransmitters can lead to an abundance of medical issues that can be potentially
life-threatening (7). For these reasons stated, it is clear to see that Munc13-1 is vital to the
success of an organism. Thus, the study of this isoform is critical in further understanding of
membrane fusion defects in both mast cells and neurons. The availability of a purified Munc13-1
protein readily available is possible through the transformation of the gene into a cloning plasmid
and the transformation of that plasmid into a model organism for protein synthesis. In this
experiment we aim to transform two expression systems with truncated Munc13-1 to harvest
purified versions of the protein for further studies.
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Chapter 2: Methods and Materials
2.1 Plasmid Information
We received wo plasmids from UT Southwestern Medical Center, one being pFastBac
GST C1C2BMunC2C, and the other pET28a C1C2BMunC2C. Both constructs were previously
truncated to only include the amino acids 529-1735, with the amino acids 1408-1452 being
replaced with an EF sequence.
2.2 Transformation into DH5 Alpha Cells
Competent cells were removed from the -80 °C freezer that they are stored in and
allowed to thaw on ice for 5 minutes. In two separate 1.5mL microfuge tube, 100uL of
competent cells were added along with 10uL of either pFastBac GST C1C2BMunC2C or
pET28a C1C2BMunC2C. The tubes were mixed by gently flicking the sides and then allowed to
incubate on ice for approximately 30 minutes. After the conclusion of the incubation period, the
cells were heat shocked at 42°C for exactly 45 seconds using a heat block. After heat shocking,
the cells were immediately returned to ice to incubate for an additional 10 minutes. Then, 75uL
of SOC media was added to each of the two tubes, and the cultures were incubated for 60
minutes at 37°C.
2.3 Preparation of LB Plates with Antibiotics
LB plates with selective media were prepared to select for transformed cells. 10g of
Bactoagar was measured out in a fresh weigh boat. 5g of Bactoagar was then transferred to two
sterilized 500mL bottle. 600mL of LB media was measured using a 1000mL sterilized cylinder.
300mL of liquid LB media was then transferred to each 500mL bottle. The bottles were labeled
appropriately and autoclaved for 20 minutes on the liquid cycle. After sterilization by autoclave,
300µL of Ampicillin (100µg/mL) was added to one bottle and 300µL of Kanamycin (50µg/mL)
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was added to the other. The bottles were then mixed. 20mL of the mixture was poured onto each
empty petri dish next to a Bunsen burner to prevent contamination. Plates were labeled, allowed
to solidify, and stored at 4 °C.
2.4 Plating of Cells from Bacterial Stock
After an incubation period of 60 minutes at 37°C, 150µL of pFastBac GST
C1C2BMunC2C mixture was plated on LB/ Ampicillin (100µg/ml) [PLATE A] and 150µL
pET28a C1C2BMunC2C mixture was plated on LB/Kanamycin (50µg/mL) [PLATE B]. 5-7
sterile glass beads were added to each plate, and the cells were spread by gently rotating the
plates in a circular motion to spread the beads. Plates were then placed upright in an incubator at
37°C for 20 minutes. After 20 minutes, the plates were inverted and allowed to incubate
overnight.
2.5 Inoculation of Culture
The workbench was sterilized with 70% ethanol and a Bunsen burner was turned on
using a strike lighter. Using a pipette aid, 6mL of sterile LB media was transferred into two preautoclaved test tubes. The test tubes were labeled for either pFastBac GST C1C2BMunC2C
[TUBE 1] or pET28a C1C2BMunC2C [TUBE 2]. 6µL of Ampicillin was then added into TUBE
1, while 6µL of Kanamycin was added into TUBE 2 Using the pipette aid, the media was mixed
thoroughly by pipetting up and down several times. Then using two wooden sticks that were
sterilized, a loop of bacteria from PLATE A was added to the TUBE 1, and a loop full of
bacteria from PLATE B was added to TUBE 2. When transferring the bacteria, it was noted that
each loop full came from one single colony on the plate and that the wooden stick did not touch
the sides of either tube during transfer. The tubes were then mixed well by brief vortexting and
stored in a shaking incubator overnight at 37°C.
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2.6 Plasmid Isolation
After an incubation period of 24 hours, the two tubes were removed from the shaking
incubator and placed on ice. Four sterilized microfuge tubes were obtained and labeled, two for
HXB-OJ41 [TUBE 1] and two for HXB-OJ39 [TUBE 2]. For each plasmid, samples were
designated sample A and sample B. Using a pipette aid 1.5mL of the culture was transferred into
each appropriate tube, and centrifuged at 13krpm for 1 minute at 4°C. The supernatant was then
disregarded, and the remaining volume of the cultures was added to each respective tube. The
four tubes were once again centrifuged at 13krpm for 1 minute at 4°C. The supernatant was
disregarded, and the pellet was vortexed until no clumps remained at the bottom of the tube. The
vortexed pellets were then resuspended in 250µL of resuspension buffer and mixed by gently
pipetting up and down, and by vortexing. Then 250µL of lysis solution was added to the
microfuge tubes and mixed by inverting the tubes 4-6 times. The lysis solution was allowed to
react for no more than 5 minutes with the mixture. After approximately 3-5 minutes, 350µL of
neutralization solution was added to each tube, and the tubes were mixed thoroughly by inverting
them ten times. The tubes were then centrifuged at 13krpm for 10 minutes at 4°C to pellet the
chromosomal DNA. After centrifugation, the supernatant of each tube was transferred to a
labeled prep spin column, without disturbing the pellet. The spin columns were centrifuged at
13krpm for 1 minute at 4°C. Flow through was discarded. 500µL of buffer PB was then added to
the spin column and centrifuged at 13krpm for 1 minute at 4°C, the flow through was discarded.
Then, 750µL of wash buffer was added to the column, and the tube was centrifuged at 13krpm
for 1 minute at 4°C. After discarding of the supernatant, the empty column was centrifuged at
13krpm for 1 minute at 4°C. The supernatant was discarded, and the empty column was
centrifuged again. After removal of the supernatant, the column was transferred to a sterile
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labeled 1.5mL microfuge tube. 50µL of elution buffer was added to the column and allowed to
incubate at room temperature for 2 minutes. Afterward, the tubes were centrifuged at 13krpm for
1 minute at 4°C, and the column was disregarded. Each sample was then measured by Nanodrop,
using the elution buffer as a blank. 1µL of each sample, including the elution buffer, was used
for Nanodrop. The data for ng/µL as well as A260/A280 and A260/A230 were recorded. The
samples were stored in -20°C.
2.7 Sequencing the Isolated Plasmids
In order to confirm the identity of the isolated plasmids, the samples were sent for
sequencing. To prepare samples, first, the primers were diluted to the needed concentration of
1.6 µM from their original stock concentration of 100mM. The primers were first diluted to a
10µM concentration, and then further diluted to the final concentration of 1.6 µM. For HXBOJ41, two primers were utilized, a forward (HXD-C65) and reverse (HXD-C66). For HXBOJ39, T7 primer was used. In total 3 tubes were prepared. Then, 4µL of the respective primer
was added into each tube. Each primer is designed to be complementary to their respective
plasmid (Table 1).
Table 1. Primer Details
Primer
Name

Plasmid
Designed
For

Nucleotide Sequence

TM

GC
content

Forward or
Reverse

HXO-C65 pFastBac

GGATTATTCATACCGTCCCA

50

45% Forward

HXO-C66 pFastBac

AATGTGGTATGGCTGAT

57

41% Reverse

TAATACGACTCACTATAGGG

57

40% NA

T7

pEt
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Purified plasmids were added to the respective tubes along with autoclaved milipore
water for a total volume of 12µL per tube (Table 2). The tubes were then sent to NCBI for
sequencing and later compared to the known nucleotide sequence of both constructs.

Tube ZK774

Tube ZK775

Tube ZK776

Table 2. Reagents Added to Sequencing Tubes
Component
Stock
Concentration
Concentration
Used

Volume Added

Autoclaved
Millipore Water

NA

NA

3.1µL

HXB-OJ39
Plasmid

162.9ng/µL

162.9ng/µL

4.9µL

T7 Primer

100 µM

1.6 µM

4µL

Component

Stock
Concentration

Concentration
Used

Volume Added

Autoclaved
Millipore Water

NA

NA

6.8µL

HXB-OJ41Plasmid 692.5ng/µL

692.5ng/µL

1.2µL

HXO-C65 Primer

100 µM

1.6 µM

4µL

Component

Stock
Concentration

Concentration
Used

Volume Added

Autoclaved
Millipore Water

NA

NA

6.8µL

HXB-OJ41Plasmid 692.5ng/µL

692.51ng/µL

1.2µL

HXO-C66 Primer

1.6 µM

4µL

100 µM

2.8 Gel Electrophoresis
In order to further confirm the identity of the isolated plasmids, both samples were run in on a
gel. The gel was prepared by first measuring out 50mL of 0.5X TBE buffer using a 100mL
cylinder and transferring the liquid to a 500mL Erlenmeyer Flask. Then, 0.35g of agarose was
weighed out and added to the flask. The mixture was heated in the microwave for two 45 second
intervals and mixed in between until the solution was clear. The mixture was then poured into a
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cast, and combs were added to create wells. The gel was allowed 20 minutes to solidify. The gel
was then transferred to a gel electrophoresis tank. The tank was filled with 0.5x TBE buffer until
it covered the gel. The first lane run was 10µL of Lambda phage DNA mixed with 2µL of
GelRed dye. The second lane was 1.4µL of isolated plasmid HXB-OJ41 and 2µL of GelRed dye.
The third lane was loaded with 6.2µL of isolated plasmid HXB-OJ39 and 2µL of GelRed dye.
The gel was run for 75 minutes on 80V and analyzed.
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Chapter 3. Results and Discussion
DH5 Alpha Cells were transformed with plasmids pFastBac GST C1C2BMunC2C, and
pET28a C1C2BMunC2C to prepare the bacterial stocks HXB-OJ41 and HXB-OJ39 respectively
(Figure 6). Plasmid pFastBac GST C1C2BMunC2C is known to carry antibiotic-resistant genes
for Ampicillin, while plasmid pET28a C1C2BMunC2C is known to carry antibiotic-resistant
genes for Kanamycin. The cells were then streaked onto LB media containing either Ampicillin
(100µg/mL) or Kanamycin (50µg/mL) to serve as selective markers. After an incubation period
of 24 hours, the strain HXB-OJ41 grown on Ampicillin was observed to have 21 individual
colonies, while the strain HXB-OJ39 grown on Kanamycin was observed to over 100 individual
colonies. Since DH5 Alpha cells do not naturally contain genes for antibiotic resistance to
Ampicillin or Kanamycin, the presence of colonies on either plate indicate successful
transformation with respective plasmids.

Figure 6. LB+Ampicillin (100µg/mL) plate with pFastBac/HXB-OJ41 colonies (left) and LB+Kanamycin
(50µg/mL) plate individual pET/HXB-OJ39 colonies (right). 21 colonies were observed for HXB-OJ41 on
Ampicillin, and over 100 colonies were observed for HXB-OJ39 on Kanamycin.
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After the successful transformation of DH5 Alpha Cells with plasmids pFastBac GST
C1C2BMunC2C and pET28a C1C2BMunC2C, plasmids were inoculated from the bacterial
stock. The inoculated plasmids were placed in a shaking incubator overnight. From each of the
two liquid inoculation cultures, the plasmid was isolated in two samples. From there, the elution
buffer from the plasmid isolation kit was used as a blank, and the Nanodrop reading of each
sample was recorded (Table 3).
When taking a Nanodrop reading, the ng/µL provides the actual concentration of the
plasmid, while the 260/280 ratio and the 260/230 ratio are used to measure the purity of the
sample. A sample is said to be pure with a 260/280 ratio of 1.8 and a 260/230 ratio of 2.0. For
the HXB-OJ41 samples A and B, both exhibited high concentrations (Table 3). Likewise, both of
their 260/280 ratios were very close to 1.8, as they were found to be 1.83(sample A) and 1.88
(sample B). Since these concentrations only had a difference of 1.6% and 4.4% from the ideal
value of 1.8, it can be concluded that they are mostly pure. The A260/230 ratio for samples A
and B of were also close to 2.0, respectively being 2.19 (percent difference of 9.5%) and 2.25
(percent difference of 12.5%) though slightly higher in differences (Table 3). However, since the
excepted range of A260/230 is 2.0-2.2, these samples can still be considered pure. For HXBOJ39, samples A and B had significantly lower concentrations of 160.4ng/µL and 168.3ng/µL
respectively (Table 3). The A260/280 ratio of sample A and B was 1.9, with a 5% difference
(Table 3). The A260/230 values for HXB-OJ39 samples A and B were also found to have higher
contamination levels than HXB-OJ41, with a 12.5% difference and a14.1% difference from the
ideal value (Table 3). This slight difference shows that there may be some minor contamination,
but the products are still mostly pure.
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Sample

ng/µL

A260/280

A260/230

HXB-OJ41 A

692.9

1.83

2.19

HXB-OJ41 B

565.9

1.88

2.25

HXB-OJ39 A

160.4

1.9

2.25

HXB-OJ39 B

168.3

1.9

2.29

Table 3. Concentrations, A260/280 ratios and A260/230 ratios of samples A and B from HXBOJ41 and HXB-OJ39 plasmid isolates. The A260/280 and A260/230 values show the products
are mostly pure, with possibly some slight contamination
Next, the samples were then run on gel electrophoresis on a 7% gel (Figure 7). The
samples were all loaded with equal amount DNA, 1ng, and equal parts dye, GelRed, to ensure
that all results were standard. A Lambda Phage Ladder was used, which is known to be 20k bp.
The truncated Munc13-1 gene is known to be approximately 4.5kb in length. The plasmid
pFastBac is known to have a length of approximately 4.5kb, while the plasmid pET is known to
have a length of 5.2kb. Thus, this would have given both samples a total length of 9-10kb. When
run on the gel using Lambda phage, the samples were compared to the gel. Sample HXB-OJ39
was noted to be only slightly above 9kb, with HXB-OJ41 being almost exactly at 9kb, which
shows evidence for them both being the correctly transformed plasmids with the appropriate
insert (Figure 7).
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Figure 7. Gel Electrophoresis of HXB-OJ41 (sample A)
and HXB-OJ39 (sample B) on 7% gel run alongside
Lambda Phage DNA at 80V for 75 Minutes. The gel
shows that HXB-OJ41 is present at 9kb, while HXBOJ39 is present slightly above 9kb, at about 10kb.

After visual confirmation that the plasmids isolated from the bacterial cultures were the
desired cultures, the two samples were sent for sequencing to further confirm their identities. The
initial set of sequence primers used for HXB-OJ41 were designed to complement the pFastBac
plasmid itself on either side of the multiple cloning sites. The first set of sequence data referred
to the HXB-OJ41 plasmid with HXO-C65 primer (Figure 8). The data shows that of the 851 base
pairs generated from sequencing, a strand of 154 base pairs showed similarity to the Munc13-1
construct from NCBI. Of that 154 base pairs sequence data (query) has a 94% similarity to the
Munc13-1 construct with 146 base pairs being identical. 8 bases in the sequence are missing, or
have not been sequenced, and 2 base pairs have been mutated to other bases, which 6 gaps in the
total length. This high similarity confirms the identity of Munc13-1 in the plasmid.
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Figure 8. Sequencing results of HXB-OJ41 with HXO-C65 primer against Munc13-1 generated
via Nucleotide BLAST on the NCBI website

For the sequencing results of HXB-OJ41 run with HXO-C65 primer, the data shows that
939 base pairs generated from sequencing showed almost identical similarity to the Munc13-1
construct from NCBI, in 3 different segments (Figure 9). The first segment had a strand of 556
base pairs, in which 555 were identical matches with one mutated base, for an overall similarity
of 99%. The next two segments, one of which had a length of 241 base pairs and the other a
length of 142, were both found to be 100% identical to the Munc13-1 construct on NCBI. No
segments were found to have any gaps. This high similarity confirms the identity of Munc13-1 in
the plasmid.
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Figure 9. Sequencing results of
HXB-OJ41 with HXO-C66 primer
against Munc13-1 generated via
Nucleotide BLAST on the NCBI
website.
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For the sequencing results of HXB-OJ39 run with T7 primer, the data shows that of the
550 base pairs generated from sequencing, a strand of 426 base pairs showed similarity to the
Munc13-1 construct from NCBI (Figure 10). Of that 426 base pairs, sequence data (query) has a
99% similarity to the Munc13-1 construct with 425 base pairs being identical, with one base
being mutated and no gaps present in the sequence. This high similarity confirms the identity of
Munc13-1 in the plasmid.

Figure 10. Sequencing results of HXB-OJ39 with T7 primer against Munc13-1 generated via
Nucleotide BLAST on the NCBI website.

The slight differences in base pair sequence suggest that although it is likely that the
sequenced plasmids are the correct constructs, it is expected that there are some mutations in the
sequences or in the plasmids that occurred during transformation. Further work in the Xu lab to
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continue this project will transform E.Coli or Sf9 with the purified plasmids, and additional
sequencing may be done to confirm the presence of the truncated Munc13-1. After the plasmid is
confirmed, protein isolation from the cell cultures will follow.
Munc13-1 has been determined to play an essential role in the regulation of membrane
fusion and degranulation in both mast cells and neurons via its interactions with other proteins
like Munc18 and the SNARE complex. A deeper understanding of the involvement of Munc13-1
in the SNARE complex assembly and disassembly is crucial to develop new treatments for the
over or under regulation of membrane fusion and the potential threats and diseases it causes to
the body.
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